Syncom Formulation (India) Ltd

SYNCOMF

Company Profile

  • Business description

    Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

  • Contact

    207, Saket Nagar
    Near Saket Club
    IndoreMP452018
    IND

    T: +91 7312560458

    https://www.sfil.in

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    1,324

Stocks News & Analysis

stocks

Stock showdown: How do ASX healthcare giants compare on key investing criteria?

Our healthcare analyst Shane Ponraj helps me compare the moatiness and growth prospects of two sector heavyweights.
stocks

Peak profit for ASX listed insurer

Simplification plan complete, organic growth now the focus.
stocks

Distribution growth for ASX income play

Cost containment and growing revenue bode well for profit margins.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,284.2051.600.56%
CAC 407,938.2934.74-0.44%
DAX 4024,293.3416.370.07%
Dow JONES (US)44,801.48136.83-0.30%
FTSE 1009,309.2021.060.23%
HKSE25,104.6161.33-0.24%
NASDAQ21,118.3554.50-0.26%
Nikkei 22542,610.17278.38-0.65%
NZX 50 Index13,194.07122.770.94%
S&P 5006,375.2320.55-0.32%
S&P/ASX 2009,019.1045.400.51%
SSE Composite Index3,771.104.890.13%

Market Movers